FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity
- PMID: 26223433
- PMCID: PMC4721545
- DOI: 10.1042/BSR20150032
FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity
Expression of concern in
-
Expression of Concern: FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity.Biosci Rep. 2022 Nov 11;42(11):BSR-2015-0032_EOC. doi: 10.1042/BSR-2015-0032_EOC. Biosci Rep. 2022. PMID: 36367178 Free PMC article. No abstract available.
Abstract
Rho-Rho kinase (Rho-ROCK) triggers an intracellular signalling cascade that regulates cell survival, death, adhesion, migration, neurite outgrowth and retraction and influences the generation and development of several neurological disorders. Although Fasudil, a ROCK inhibitor, effectively suppressed encephalomyelitis (EAE), certain side effects may limit its clinical use. A novel and efficient ROCK inhibitor, FSD-C10, has been explored. In the present study, we present chemical synthesis and structure of FSD-C10, as well as the relationship between compound concentration and ROCK inhibition. We compared the inhibitory efficiency of ROCKI and ROCK II, the cell cytotoxicity, neurite outgrowth and dendritic formation, neurotrophic factors and vasodilation between Fasudil and FSD-C10. The results demonstrated that FSD-C10, like Fasudil, induced neurite outgrowth of neurons and dendritic formation of BV-2 microglia and enhanced the production of neurotrophic factor brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF) and neurotrophin-3 (NT-3). However, the cell cytotoxicity and vasodilation of FSD-C10 were relatively small compared with Fasudil. Although Fasudil inhibited both ROCK I and ROCK II, FSD-C10 more selectively suppressed ROCK II, but not ROCK I, which may be related to vasodilation insensitivity and animal mortality. Thus, FSD-C10 may be a safer and more promising novel ROCK inhibitor than Fasudil for the treatment of several neurological disorders.
Keywords: FSD-C10; Fasudil; Rho kinase; Rho kinase inhibitor.
© 2015 Authors.
Figures









References
-
- Sun X., Minohara M., Kikuchi H., Ishizu T., Tanaka M., Piao H., Osoegawa M., Ohyagi Y., Shimokawa H., Kira J. The selective Rhokinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2006;180:126–134. doi: 10.1016/j.jneuroim.2006.06.027. - DOI - PubMed
-
- Hou S.W., Liu C.Y., Li Y.H., Yu J.Z., Feng L., Liu Y.T., Guo M.F., Xie Y., Meng J., Zhang H.F., et al. Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effect. CNS Neurosci. Ther. 2012;18:909–917. doi: 10.1111/cns.12002. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials